Cervical Cancer Diagnostic Tests Market, By Test Type, By Age Group, and By Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Cervical cancer occurs in the cells of the cervix. Pap smear, colposcopy, and ECC procedures are performed for the diagnosis of cervical cancer. Increasing product approvals along with increasing prevalence of cervical cancer in emerging economies are expected to assist the growth of the market during the forecast period. Furthermore, increasing awareness regarding cervical cancer in emerging economies and increasing funding for R&D in diagnosis of cervical cancer are expected to drive growth of the market during the forecast period.

Market Dynamics

The increasing prevalence of cervical cancer is expected to drive the global cervical cancer diagnostic tests market growth during the forecast period. For instance, according to the World Health Organization (WHO), around 570,000 new cases of cervical cancer were diagnosed globally in 2018.

Moreover, according to the World Cancer Research Fund International, cervical cancer is the fourth most common cancer in women. The table below provides the top 10 countries with highest rates of cervical cancer (according to the World Cancer Research Fund International) in 2018:

Rank Country Age Standardized Rate Per 100,000

1 Eswatini 75.3

2 Malawi 72.9

3 Zambia 66.4

4 Zimbabwe 62.3

5 Tanzania 59.1

6 Burundi 57.4

7 Uganda 54.8

8 Lesotho 52.1

9 Madagascar 51.6

10 Cosmos 50.9

Key features of the study:

• This report provides in-depth analysis of the global cervical cancer diagnostic tests market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2022 - 2028), considering 2021 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global cervical cancer diagnostic tests market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
• Key companies covered as a part of this study include DYSIS Medical Ltd., Abbott Laboratories, Becton, Dickinson and Company, The Cooper Companies, Inc., Danaher Corporation, F. Hoffmann-La Roche AG, Quest Diagnostics, Arbor Vita Corporation, Hologic, Inc., Zilico Ltd, and Qiagen
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global cervical cancer diagnostic tests market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cervical cancer diagnostic tests market

Detailed Segmentation:

• Global Cervical Cancer Diagnostic Tests Market, By Test Type:
  • Pap Smear Test
  • Colposcopy Test
  • ECC Test
  • HPV Test
• Global Cervical Cancer Diagnostic Tests Market, By Age Group:
  • Age 20 - 40
  • Age Above 40
• Global Cervical Cancer Diagnostic Tests Market, By Region:
  • North America
    • By Test Type
    • Pap Smear Test
    • Colposcopy Test
    • ECC Test
    • HPV Test
    • By Age Group
    • Age 20 - 40
    • Age Above 40
    • By Country
    • U.S.
    • Canada
  • Latin America
    • By Test Type
    • Pap Smear Test
    • Colposcopy Test
    • ECC Test
    • HPV Test
    • By Age Group
    • Age 20 - 40
    • Age Above 40
    • By Country
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • By Test Type
    • Pap Smear Test
    • Colposcopy Test
    • ECC Test
    • HPV Test
    • By Age Group
    • Age 20 - 40
    • Age Above 40
    • By Country
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • By Test Type
    • Pap Smear Test
    • Colposcopy Test
    • ECC Test
    • HPV Test
    • By Age Group
    • Age 20 - 40
    • Age Above 40
    • By Country
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • By Test Type
    • Pap Smear Test
    • Colposcopy Test
    • ECC Test
    • HPV Test
    • By Age Group
    • Age 20 - 40
    • Age Above 40
    • By Country
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    • By Test Type
    • Pap Smear Test
    • Colposcopy Test
    • ECC Test
    • HPV Test
    • By Age Group
    • Age 20 - 40
    • Age Above 40
    • By Country/Region
    • South Africa
    • Central Africa
    • North Africa
• Company Profiles
  • DYSIS Medical Ltd. *
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
  • Abbott Laboratories
  • Becton, Dickinson and Company
  • The Cooper Companies, Inc.
  • Danaher Corporation
  • Hoffmann-La Roche AG
  • Quest Diagnostics
  • Arbor Vita Corporation
  • Hologic, Inc.
  • Zilico Ltd
  • Qiagen

"*" marked represents similar segmentation in other categories in the respective section.